the control group 1:Subcutaneously injected 50mg per week for 24 weeks. From 24 weeks to 52 weeks, Yisaipu dosage reduction combined with traditional Chinese medicine was maintained
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Conditions
Rheumatoid arthritis
Phase 4
A prospective, multicenter, randomized, open study on the efficacy and safety of Yisaipu combined with traditional Chinese medicine for standard treatment and maintenance therapy in RA patients who failed traditional DMARDs treatment
Active, not recruitingITMCTR1900002628
Start: 2020-04-01Updated: 2023-02-20
A prospective, multicenter, randomized, open study on the efficacy and safety of Yisaipu combined with traditional Chinese medicine for standard treatment and maintenance therapy in RA patients who failed traditional DMARDs treatment
Active, not recruitingChiCTR1900026270
Start: 2020-04-01Updated: 2020-04-27